vs
Side-by-side financial comparison of Cytek Biosciences, Inc. (CTKB) and Ouster, Inc. (OUST). Click either name above to swap in a different company.
Ouster, Inc. is the larger business by last-quarter revenue ($62.2M vs $62.1M, roughly 1.0× Cytek Biosciences, Inc.). On growth, Ouster, Inc. posted the faster year-over-year revenue change (106.6% vs 8.1%). Cytek Biosciences, Inc. produced more free cash flow last quarter ($-1.8M vs $-37.2M). Over the past eight quarters, Ouster, Inc.'s revenue compounded faster (54.8% CAGR vs 17.7%).
Cytek Biosciences, Inc. develops, manufactures and sells high-performance flow cytometry systems, associated reagents and analysis software. Its solutions serve life science research, clinical diagnostics and biopharmaceutical sectors, with a global customer base across North America, Europe and the Asia-Pacific region.
Ouster, Inc. is an American lidar technology company headquartered in San Francisco, California. It builds high-resolution, digital 3D lidar sensors for use in autonomous vehicles, industrial, robotics, drones, mapping, defense, and security systems.
CTKB vs OUST — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $62.1M | $62.2M |
| Net Profit | $-44.1M | — |
| Gross Margin | 52.9% | 60.2% |
| Operating Margin | -9.0% | 1.5% |
| Net Margin | -70.9% | — |
| Revenue YoY | 8.1% | 106.6% |
| Net Profit YoY | -557.1% | — |
| EPS (diluted) | — | $0.10 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $62.1M | $62.2M | ||
| Q3 25 | $52.3M | $39.5M | ||
| Q2 25 | $45.6M | $35.0M | ||
| Q1 25 | $41.5M | $32.6M | ||
| Q4 24 | $57.5M | $30.1M | ||
| Q3 24 | $51.5M | $28.1M | ||
| Q2 24 | $46.6M | $27.0M | ||
| Q1 24 | $44.9M | $25.9M |
| Q4 25 | $-44.1M | — | ||
| Q3 25 | $-5.5M | $-21.7M | ||
| Q2 25 | $-5.6M | $-20.6M | ||
| Q1 25 | $-11.4M | $-22.0M | ||
| Q4 24 | $9.6M | — | ||
| Q3 24 | $941.0K | $-25.6M | ||
| Q2 24 | $-10.4M | $-23.9M | ||
| Q1 24 | $-6.2M | $-23.8M |
| Q4 25 | 52.9% | 60.2% | ||
| Q3 25 | 52.7% | 42.1% | ||
| Q2 25 | 52.3% | 45.2% | ||
| Q1 25 | 48.6% | 41.3% | ||
| Q4 24 | 58.5% | 43.8% | ||
| Q3 24 | 56.3% | 38.3% | ||
| Q2 24 | 54.6% | 33.7% | ||
| Q1 24 | 51.3% | 28.6% |
| Q4 25 | -9.0% | 1.5% | ||
| Q3 25 | -17.6% | -61.4% | ||
| Q2 25 | -23.3% | -76.5% | ||
| Q1 25 | -36.1% | -73.0% | ||
| Q4 24 | 5.2% | -85.1% | ||
| Q3 24 | -8.2% | -98.0% | ||
| Q2 24 | -18.3% | -93.6% | ||
| Q1 24 | -23.9% | -99.5% |
| Q4 25 | -70.9% | — | ||
| Q3 25 | -10.5% | -55.0% | ||
| Q2 25 | -12.2% | -58.8% | ||
| Q1 25 | -27.5% | -67.5% | ||
| Q4 24 | 16.8% | — | ||
| Q3 24 | 1.8% | -91.1% | ||
| Q2 24 | -22.4% | -88.4% | ||
| Q1 24 | -13.8% | -91.9% |
| Q4 25 | — | $0.10 | ||
| Q3 25 | — | $-0.37 | ||
| Q2 25 | — | $-0.38 | ||
| Q1 25 | — | $-0.42 | ||
| Q4 24 | — | $-0.46 | ||
| Q3 24 | — | $-0.54 | ||
| Q2 24 | — | $-0.53 | ||
| Q1 24 | — | $-0.55 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $90.9M | $208.6M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $341.7M | $261.7M |
| Total Assets | $461.5M | $349.5M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $90.9M | $208.6M | ||
| Q3 25 | $93.3M | $244.5M | ||
| Q2 25 | $75.5M | $226.5M | ||
| Q1 25 | $95.3M | $168.2M | ||
| Q4 24 | $98.7M | $172.0M | ||
| Q3 24 | $162.3M | $151.4M | ||
| Q2 24 | $177.9M | $184.2M | ||
| Q1 24 | $168.8M | $187.8M |
| Q4 25 | $341.7M | $261.7M | ||
| Q3 25 | $378.6M | $247.4M | ||
| Q2 25 | $377.6M | $221.0M | ||
| Q1 25 | $379.6M | $167.9M | ||
| Q4 24 | $395.7M | $180.9M | ||
| Q3 24 | $385.5M | $171.7M | ||
| Q2 24 | $389.1M | $170.6M | ||
| Q1 24 | $392.6M | $167.2M |
| Q4 25 | $461.5M | $349.5M | ||
| Q3 25 | $494.9M | $353.8M | ||
| Q2 25 | $493.3M | $321.8M | ||
| Q1 25 | $482.6M | $268.6M | ||
| Q4 24 | $499.5M | $276.1M | ||
| Q3 24 | $491.2M | $255.2M | ||
| Q2 24 | $483.7M | $309.9M | ||
| Q1 24 | $492.1M | $317.7M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-771.0K | $-15.4M |
| Free Cash FlowOCF − Capex | $-1.8M | $-37.2M |
| FCF MarginFCF / Revenue | -2.9% | -59.8% |
| Capex IntensityCapex / Revenue | 1.6% | 35.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-8.8M | $-64.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-771.0K | $-15.4M | ||
| Q3 25 | $-3.9M | $-18.3M | ||
| Q2 25 | $108.0K | $-1.3M | ||
| Q1 25 | $-125.0K | $-4.9M | ||
| Q4 24 | $2.0M | $-2.6M | ||
| Q3 24 | $13.2M | $-3.8M | ||
| Q2 24 | $6.2M | $-21.6M | ||
| Q1 24 | $4.0M | $-5.7M |
| Q4 25 | $-1.8M | $-37.2M | ||
| Q3 25 | $-4.6M | $-20.0M | ||
| Q2 25 | $-1.5M | $-2.2M | ||
| Q1 25 | $-974.0K | $-5.4M | ||
| Q4 24 | $1.1M | $-4.0M | ||
| Q3 24 | $12.2M | $-4.3M | ||
| Q2 24 | $5.2M | $-22.0M | ||
| Q1 24 | $3.4M | $-7.1M |
| Q4 25 | -2.9% | -59.8% | ||
| Q3 25 | -8.7% | -50.7% | ||
| Q2 25 | -3.2% | -6.3% | ||
| Q1 25 | -2.3% | -16.6% | ||
| Q4 24 | 1.9% | -13.3% | ||
| Q3 24 | 23.7% | -15.4% | ||
| Q2 24 | 11.0% | -81.5% | ||
| Q1 24 | 7.6% | -27.4% |
| Q4 25 | 1.6% | 35.0% | ||
| Q3 25 | 1.3% | 4.3% | ||
| Q2 25 | 3.5% | 2.5% | ||
| Q1 25 | 2.0% | 1.7% | ||
| Q4 24 | 1.6% | 4.8% | ||
| Q3 24 | 2.0% | 2.0% | ||
| Q2 24 | 2.3% | 1.3% | ||
| Q1 24 | 1.3% | 5.3% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.21× | — | ||
| Q3 24 | 14.05× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CTKB
| Products | $46.6M | 75% |
| Services | $15.5M | 25% |
OUST
Segment breakdown not available.
